The problem of combined diseases in the reproductive system of the women


  • O.Yu. Kruk
Keywords: combined diseases; myoma of the uterus; polycystic ovary; dyshormonal diseases of the mammary glands; hyperplastic processes; hyperestrogenemia.

Abstract

Annotation. This article highlights the urgent problem of combined diseases of women's reproductive system. On the basis of theoretical analysis, generalized statistics for recent years are presented. The modern concepts of pathogenesis of diseases of the uterus and mammary glands, their correlation, as well as models of diagnosis and treatment are considered. Indeed, a more in-depth understanding of the problems of the combined pathology of the woman’s reproductive system (diseases of the uterus, ovaries, mammary gland), namely etiopathogenesis, diagnostic and treatment algorithms, will reduce the incidence of women of reproductive and perimenopausal age, as well as improve their quality of life. Only having the fullness of information about the state of the reproductive system of women, the doctor is able to prescribe thoughtful and effective treatment.

References

1. Arakelov, S. E., Maslennikova, M. N., Pavlova, E. A., & Ordiyanc, I. M. (2012). Effektivnost kompleksnogo lecheniya bolnyh s dobrokachestvennymi displaziyami molochnih zhelez i miomoj matki [Effect of complex treatment of patients with benign breast disorders and uterine myomas]. Ginekologiya – Gynecology, 90–93.

2. Bolieva, G. U. (2006). Dobrokachestvennye zabolevaniya molochnih zhelez pri giperplasticheskih procesah endo- i miometriya [Benign diseases of the mammary glands with hyperplastic processes of endo - and myometrium]. (Dis. kand. med. nauk). Dushanbe: [b. i.].

3. Volobuev, A. I. (2003). Rezultaty obsledovaniya zhenshin s sochetannymidobrokachestvennymigiperplasticheskimiprocessamimolochnyhzhelez i polovyh organov [The results of a survey of women with combined benign hyperplastic and mammary glands and genitals]. Akusherstvo i ginekologiya – Obstetrics and gynecology, 5, 27–31.

4. Zhulkevych, I. V., Smiian, S. I., Havryliuk, M. Ye., Kmita, H. H., Kramar, L. T., & Korchynska, R. M. (2000). Metodolohichni pidkhody do vyvchennia yakosti zhyttia v hematolohichnykh doslidzhenniakh [Methodological approaches to the study of quality of life in hematological research]. Visnyk naukovykh doslidzhen – Bulletin of scientific researches, 3, 16–23.

5. Kardanova, M. H. (2007). Vliyanie gisterektomii i zamestitelnoj gormonalnoj terapii na sostoyanie molochnih zhelez u zhenshin reproduktivnogo vozrasta (Dis. kand. med. nauk). Moskva: [b.i.]. [The effect of hysterectomy and hormone replacement therapy on the condition of the mammary glands in women of reproductive age]. Moskva: [b.i.].

6. Kiselev, V. I., Sidorova, I. S., Unanyan, A. L., & Mujzhnek, E. L. (2010). Giperplasticheskie processy organov zhenskoj reproduktivnoj sistemy: teoriya i praktika [Hyperplastic processes of the organs of the female reproductive system: theory and practice]. Moskva: Medpraktika.

7. Kravchenko, E. N., & Ozherelieva, M. A. (2014). Sostoianye molochnыkh zhelez pry hynekolohycheskykh zabolevanyiakh (lyteraturnыi obzor) [The state of the mammary glands in gynecological diseases (literature review)]. Mat y dytia v Kuzbasse – Mother and Baby in Kuzbass, 2(57), 19–23. Vziato s https://www.elibrary.ru/item.asp?id=22475757.

8. Kryvokulskyi, B. D., & Zhulkevych, I. V. (2018). Ryzyk-adaptovani pidkhody do profilaktyky trombotychnykh uskladnen pry histerektomii [Risk adapted approaches to prophylaxis of thrombotic complications at gisterectomy]. Shpytalna khirurhiia. Zhurnal imeni L. Ya. Kovalchuka – Hospital Surgery. Journal named by L.Ya. Kovalchuk, 2, 78–83. Vziato z http://nbuv.gov.ua/UJRN/shpkhir_2018_2_15.

9. Kryvokulsky, B.D., Zhulkevich, I.V., Kryvokulsky, D.B., & Shkrobot L.V. (2018). Vyvchennia vplyvu viku ta indeksu komorbidnosti na ryzyk trombotychnykh uskladnen u khvorykh na rak endometriia na dooperatsiinomu etapi [Studying the influence of age and comorbidity index on the thrombotic complications risk in patients with endometrial cancer at preoperative stage]. Visnyk naukovykh doslidzhen – Bulletin of Scientific Research, 2, 150–154. DOI: https://doi.org/10.11603/2415-8798.2018.2.9212.

10. Ovsyannikova, T. V. (2006). Disgormonalnaya patologiya molochnih zhelez – vzglyad ginekologa. Dobrokachestvennye zabolevaniya molochnih zhelez [Dyshormonal pathology of the mammary glands - a gynecologists vision. Benign diseases of the mammary glands]. V Klinicheskie lekcii po materialam shkoly “Sovremennye aspekty patogeneza, diagnostiki i lecheniya zabolevanij molochnih zhelez” [In “Clinical lectures on the materials of the school Modern aspects of pathogenesis, diagnosis and treatment of diseases of the mammary glands”]. Moskva: [b.i.].

11. Ordiyanc, I. M., Kardanova, V. V., Pavlova, E. A., & Maslennikova, M. N. (2013). K probleme lecheniya dobrokachestvennyh displazij molochnih zhelez v sochetanii s miomoj matki [On the problem of treating benign breast dysplasia in combination with uterine myoma]. Ulyanovskij mediko-biologicheskij zhurnal – Ulyanovsk Medical Biological Journal, 3, 94–100.

12. Radzinskij, V. E., Ordiyanc, I. M., Maslennikova, M. N., & Pavlova, E. A. (2014). Molochnye zhelezy i ginekologicheskie zabolevaniya: ot obshnosti patogeneticheskih vozzrenij k prakticheskim resheniyam [Mammary glands and gynecological diseases: from a common pathogenetic view to practical solutions]. Reproduktivnaya endokrinologiya – Reproductive endocrinology, 2(16), 72–80. Vzyato s http://nbuv.gov.ua/UJRN/Zdzh_2016_6_21.

13. Cherenkov, V. G., Petrov, A. B., Tverezovskij, S. A., & Strozhenkov, M. M. (2014). Ot patogeneza opuholej molochnih zhelez i ginekologicheskih boleznej k prakticheskomu resheniyu problem [From the pathogenesis of breast tumors and gynecological diseases to the practical solution to the problem]. Rossijskij onkologicheskij zhurnal – Russian Oncology Journal, 5, 47–51.

14. Shelyhin, M. S. (2014). Poiednana dobroiakisna patolohiia matky i hrudnykh zaloz u zhinok reproduktyvnoho viku: diahnostyka i taktyka likuvannia [Combined benign uterine and breast pathology in reproductive women: diagnosis and treatment tactics]. Zdorove zhenshiny – Womans health, 9(95), 158–160.

15. Shhagapsoeva, T. B. (2010). Diagnostika zabolevanij molochnih zhelez u zhenshin starshe 40 let na fone ginekologicheskoj patologii [Diagnosis of diseases of the mammary glands in women older than 40 years against the background of gynecological pathology. abstract] (Dis. kand. med. nauk). Moskva: [b.i.].

16. Abbott, J. A. (2017). Adenomyosis and Abnormal Uterine Bleeding (AUB–A)–Pathogenesis, diagnosis, and management. Best Pract. Res. Clin. Obstet. Gynaecol., 40, 68–78. doi: 10.1016/j.bpobgyn.2016.09.006.

17. Carauleanu, A., Socolov, R., Rugina, V., Gabia, O., Carauleanu, D. M., Lupascu, I. A., & Socolov, D. (2016). Comparisons between the non-proliferative and proliferative therapy in fibrocystic mastosis. Rev. Med. Chir. Soc. Med. Nat. Iasi, 120 (2), 321–327. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/27483712.

18. Charlson, M., Wells, M.T., Ullman, R., King, F., & Shmukler, C. (2014). The Charlson Comorbidity Index Can Be Used Prospectively to Identify Patients Who Will Incur High Future Costs. Plos One. https://doi.org/10.1371/journal.pone.0112479.

19. Claus, E. B., Stowe, M., & Carter, D. (2013). Family history of breast and ovarian cancer and risk of breast carcinoma in situ. Breast Cancer Res. Treat, 78(1), 7–15. DOI:10.1023/a:1022147920262.

20. Czernobilsky, B. (2015). Endometriosis. In H. Fox (Ed.). Obstetrical and Gynecological Pathology (p. 763–777). New York: Churchill Living stone.

21. de Villiers, T. J., Pines, A., Panay, N., Gambacciani, M., Archer, D. F., Baber, R. J., … Sturdee, D. W. (2013). Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric, 16, 316–337. doi: 10.3109/13697137.2013.795683.

22. Gold, E. B., Crawford, S. L., Avis, N. E., Crandall, C. J., Matthews, K. A., Waetjen, L. E., … Harlow, S. D. (2013). Factors related to age at natural menopause: longitudinal analyses from SWAN. Am. J. Epidemiol., 178, 70–83. doi: 10.1093/aje/kws421.

23. Gorban, N. Ye., Zadorozhna, T. D., Vovk, I. B., & Zhulkevych, I. V. (2019). Morphological features of uterine polyps in females of reproductive age. Вісник наукових досліджень, 2, 47–52. Retrieved from http://nbuv.gov.ua/UJRN/vndt_2019_2_11.

24. Hammad, A. E. (2016). Women and health security. Wld Hlth Statist. Quart, 49(2), 74–77.

25. Horban, N. Y., Vovk, I. B., Lysiana, T. O., Ponomariova, I. H., & Zhulkevych, I. V. (2019). Peculiarities of Uterine Cavity Biocenosis in Patients with Different Types of Endometrial Hyperproliferative Pathology. Journal of Medicine and Life, 12 (3), 266–270. doi: 10.25122/jml-2019-0074.

26. Khasanova, G. H., Tukhtaeva, N. K., Saidov, V. M., & Zhulkevych, I. V. (2019). Modern approaches to diеtotherapy in hypertensive disease. Вісник наукових досліджень, 1, 11–14.

27. Lole di Francesc Menopause State of the art. (2011). 540 p.

28. Mansel, R. E., Webster, D. J. T., & Sweetland, H. M. (2009). Breast pain and nodularity. Benign disorders and diseases of the breast (pp. 107–139). Elsevier.

29. Naftalin, J., & Jurkovic, D. (2013). The endometrial–myometrial junction: a fresh look at a busy crossing. Ultrasound Obstet. Gynecol., 34(1), 1–11. doi: 10.1002/uog.6432.

30. Randolph, J. F. Jr., Zheng, H., Sowers, M. R., Crandall, C., Crawford, S., Gold, E. B., & Vuga, M. (2011). Change in Follicle–Stimulating Hormone and Estradiol Across the Menopausal Transition: Effect of Age at the Final Menstrual Period. J. Clin. Endocrinol. Metab., 96(3), 746–754. doi: 10.1210/jc.2010-1746.

31. Vaĭnshteĭn, S. G., Masik, A. M., & Zhulkevich. I. V. (1988). Food fiber – research results and outlook. Voprosy pitaniia, 6, 8–12.

32. Vainstein, S. G., Zhulkevich, I. V., Dudkin, M. S., & Cherno, N. K. (1987). Food fibers as modifiers of homeostasis in patients with diabetes mellitus. Terapevticheskii arkhiv, 59 (11), 29–31.

33. Vessey, M., & Yeates, D. (2017). Oral contraceptives and benign breast disease: an update of findings in a large cohort study. Contraception, 76(6), 418–424. DOI:10.1016/j.contraception.2007.08.011.

34. WHO and the International Bank for Reconstruction and Development. (2017). Tracking Universal Health Coverage: 2017 Global Monitoring Report. 88 p.

35. Woźniak, A., & Woźniak, S. (2017). Ultrasonography of uterine leiomyomas. Prz Menopauzalny, 16 (4), 113–117. doi: 10.5114/pm.2017.72754.

36. Yao, J. P., Hao, Y. Z., Chang, Q., Geng, C. Y., Chen, Y., Zhao, W. P., … Zhou, X. (2017). Value of Ultrasonographic Features for Assessing Malignant Potential of Complex Cystic Breast Lesions. J. Ultrasound Med., 36(4), 699–704. doi: 10.7863/ultra.16.05012.
Published
2019-12-30
How to Cite
Kruk, O. (2019). The problem of combined diseases in the reproductive system of the women. Reports of Vinnytsia National Medical University, 23(4), 733-739. https://doi.org/https://doi.org/10.31393/reports-vnmedical-2019-23(4)-30